Mitomycin C-Based Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Colorectal Cancer With Peritoneal Metastasis
CRS combined with MMC-based HIPEC provides a significant survival benefit for selected patients with colorectal cancer and isolated peritoneal metastasis. These findings support the role of MMC-based HIPEC as an effective locoregional treatment strategy.
Authors
- Kitinut Timudom
- Chayanit Sirisai
- Saipan Khunpakdee
- Hathaiwan Moungthard
Institutions
- National Cancer Institute of Thailand (TH)
Publication Details
- Journal
- Cureus
- Published
- 2026-01-27
- DOI
- https://doi.org/10.7759/cureus.102405
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute